The first stop for professional medicines advice

Specialty

267 results

Applied filters

Using and prescribing thiamine in alcohol dependence

6 June 2024Intramuscular and intravenous thiamine can be used to prevent complications of alcohol dependence such as Wernicke’s encephalopathy.

Treating lice during breastfeeding

31 May 2024Wet combing, dimeticone, malathion or permethrin can be used during breastfeeding; choice will depend on the indication. Other treatments can be considered.

Switching strategies for antidepressants

22 May 2024The choice of antidepressant switching strategy depends on the person and antidepressant. We describe the current strategies and their application.

Calculating and using the Child-Pugh score

17 May 2024The Child-Pugh score is used to estimate the severity of liver disease in patients with cirrhosis, and by drug manufacturers to suggest dose adjustments.

Prescribing and using thiamine to prevent refeeding syndrome

2 May 2024Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.

Information resources for managing medicines in liver impairment

1 May 2024SPS and other information resources to help healthcare professionals provide advice on medicines in liver impairment.

Assessing liver function and interpreting liver blood tests

1 May 2024We explain how to assess liver function including the purpose of liver blood tests, how to interpret them and what to do if they are abnormal.

Questions to ask when giving medicines advice in liver impairment

1 May 2024Information should be gathered about the history of liver impairment or the type of liver disease to enable a risk assessment and decisions about treatment.

Choosing a medicine to delay periods

1 May 2024Norethisterone is the licensed choice for delaying menstruation, but it is not always the most appropriate choice.

Primary care discussions: HRT use in clinical practice

24 April 2024This ‘on the couch’ webinar, the second in a series of two, addressed questions around the challenges faced by pharmacists with HRT decision making.